LAVAL, Quebec, Jan. 17, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma (“Acasti”) (TSX.V:APO), a Neptune Technologies & Bioressources Inc’s (“Neptune”) subsidiary, today report its financial results for the three and nine-month periods ended November 30, 2011.
